Gao Zhang, Ph.D.
Affiliations: | 2012 | Bioengineering | University of Pennsylvania, Philadelphia, PA, United States |
Area:
Biomedical Engineering, Oncology, Cell BiologyGoogle:
"Gao Zhang"Parents
Sign in to add mentor| Meenhard Herlyn | grad student | 2012 | Penn | |
| (Induction of cellular senescence as a novel therapeutic strategy for melanoma treatment.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Zhang L, Jiang Y, Zhang G, et al. (2023) The diversity and dynamics of tumor-associated macrophages in recurrent glioblastoma. Frontiers in Immunology. 14: 1238233 |
| Sun Y, Revach OY, Anderson S, et al. (2023) Targeting TBK1 to overcome resistance to cancer immunotherapy. Nature |
| Wei S, Yin D, Yu S, et al. (2022) Anti-tumor Activity of a Mitochondrial Targeted HSP90 Inhibitor in Gliomas. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research |
| Wang H, Chen H, Liu S, et al. (2021) Costimulation of γδTCR and TLR7/8 promotes Vδ2 T-cell antitumor activity by modulating mTOR pathway and APC function. Journal For Immunotherapy of Cancer. 9 |
| Du K, Wei S, Wei Z, et al. (2021) Pathway signatures derived from on-treatment tumor specimens predict response to anti-PD1 blockade in metastatic melanoma. Nature Communications. 12: 6023 |
| Yu S, Wei S, Savani M, et al. (2021) A Modified Nucleoside 6-thio-2'-deoxyguanosine Exhibits Anti-tumor Activity in Gliomas. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research |
| Liu J, Rebecca VW, Kossenkov AV, et al. (2021) Neural crest-like stem cell transcriptome analysis identifies LPAR1 in melanoma progression and therapy resistance. Cancer Research |
| Wang B, Zhang W, Zhang G, et al. (2021) Targeting mTOR signaling overcomes acquired resistance to combined BRAF and MEK inhibition in BRAF-mutant melanoma. Oncogene |
| Liu D, Lin JR, Robitschek EJ, et al. (2021) Evolution of delayed resistance to immunotherapy in a melanoma responder. Nature Medicine |
| Wang L, Gao Y, Zhang G, et al. (2020) Enhancing KDM5A and TLR activity improves the response to immune checkpoint blockade. Science Translational Medicine. 12 |